Cohort Study for Gastric MALT Lymphoma
NCT06454149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-06-12
Summary
The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls.
Participants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).
Conditions
- Gastric MALT Lymphoma
Interventions
- OTHER
-
MALT lymphoma
New diagnosis with gastric MALT lymphoma
Sponsors & Collaborators
-
Kangbuk Samsung Hospital
collaborator OTHER -
Korea University Ansan Hospital
collaborator OTHER -
Seoul National University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-06
- Primary Completion
- 2028-06-05
- Completion
- 2031-06-05
Countries
- South Korea
Study Locations
More Related Trials
-
Samsung Medical Center-Lymphoma Cohort Study
NCT00822731 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
NCT07032103 ·Status: RECRUITING
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
NCT01054781 ·Status: COMPLETED ·Phase: PHASE2
-
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
NCT04061850 ·Status: COMPLETED
-
MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin
NCT03778619 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)
NCT00515957 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Lymphoma in Asia
NCT01584141 ·Status: COMPLETED
-
Gemcitabine in NK/T Cell Lymphoma
NCT01660568 ·Status: COMPLETED
-
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL
NCT02445404 ·Status: UNKNOWN ·Phase: PHASE2
-
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
NCT01761682 ·Status: TERMINATED
-
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea
NCT04048395 ·Status: UNKNOWN
-
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
NCT04414163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
TreAtments and outComes in paTients With prImary CutAneous Lymphoma
NCT05518851 ·Status: RECRUITING
-
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
NCT05827341 ·Status: COMPLETED
-
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327 ·Status: RECRUITING
-
Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
NCT00846157 ·Status: UNKNOWN ·Phase: PHASE3
-
Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression
NCT03977623 ·Status: UNKNOWN
-
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
NCT01202448 ·Status: COMPLETED ·Phase: NA
-
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
NCT06552572 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
NCT02987127 ·Status: UNKNOWN
-
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT05907447 ·Status: UNKNOWN
-
Gemcitabine for Marginal Zone Lymphoma
NCT00337259 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
NCT05485753 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma
NCT01678417 ·Status: UNKNOWN ·Phase: PHASE2